Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Hormone receptors and HER-2 changes during breast cancer progression: clinical implications].

Bulletin du cancer - 1 Oct 2011

Jacot William, Pouderoux Stéphane, Bibeau Frédéric, Leaha Cristina, Chateau Marie-Christine, Chapelle Angélique, Romieu Gilles

Abstract excerpt

Breast cancer remains a major public health problem. Even if there is an increase in this cancer curability, metastatic breast cancer remains a lethal disease in the vast majority of cases. Therapeutic advances in the chemotherapeutic and targeted therapies fields induced an increase in survival, however the proportion of long survivors remains low. Phenotypic instability, an early process initiated during tumour...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Breast Neoplasms
Share to Disease Progression

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Lymphatic Metastasis

Share to Neoplasm Proteins

Share to Neoplasm Recurrence, Local

Share to Receptor, ErbB-2

Share to Receptors, Estrogen

Share to Receptors, Progesterone

Source

Identifiers

PMID: 21908263
DOI: 10.1684/bdc.2011.1434

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Hormone receptors and HER-2 changes during breast cancer progression: clinical implications].PMID 21908263Read ↗

Role of hormone receptors and HER2 as prospective molecular markers for breast cancer: An updateSemantic proximity Read ↗

The diverse signaling network of EGFR, HER2, HER3 and HER4 tyrosine kinase receptors and the consequences for therapeutic approaches.Semantic proximity Read ↗

Molecular Concordance Between Primary Breast Cancer and Matched MetastasesSemantic proximity Read ↗

Triple positive breast cancer: a distinct subtype?Semantic proximity Read ↗

The hormone receptor status in breast cancer and the relationship of subtypes with clinicopathological features.Semantic proximity Read ↗

Unusual Patterns of HER2 Expression in Breast Cancer: Insights and PerspectivesSemantic proximity Read ↗

Natural History and Characteristics of ERBB2-mutated Hormone Receptor-positive Metastatic Breast Cancer: A Multi-institutional Retrospective Case-control Study from AACR Project GENIE.Semantic proximity Read ↗

[Androgen receptor-positive triple negative breast cancer: From biology to therapy].Semantic proximity Read ↗

Crosstalk between the Estrogen Receptor and the HER Tyrosine Kinase Receptor Family: Molecular Mechanism and Clinical Implications for Endocrine Therapy ResistanceSemantic proximity Read ↗

The Prognosis and Predictive Value of Estrogen Negative/Progesterone Positive (ER-/PR+) Phenotype: Experience of 1159 Primary Breast Cancer from a Single Institute.Semantic proximity Read ↗

Factors predictive of response to hormone therapy in breast cancer.Semantic proximity Read ↗

Age related influence of triple receptor status on metastatic breast cancer post relapse survival.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.